244
Participants
Start Date
May 23, 2015
Primary Completion Date
January 31, 2018
Study Completion Date
January 4, 2018
Injectafer
Normal Saline
Richmond University Medical Center, Staten Island
Montefiore Medical Center, The Bronx
East Chester Cancer Center, The Bronx
The Brookdale University Hospital and Medical Center, Brooklyn
Gettysburg Cancer Center, Gettysburg
Rcca Md, Llc, Bethesda
Antietam Oncology and Hematology Group, P.C., Hagerstown
Bon Secours St. Francis Medical Center, Midlothian
Waverly Hematology Oncology, Cary
Kinston Medical Specialists, Kinston
Charleston Hematology/Oncology Associates, P.A., Charleston
Carolina Blood and Cancer Care, PA, Rock Hill
AR Development Solutions, Miami Lakes
Lakes Research, Miami Lakes
University Cancer Institute, Boynton Beach
H. Lee Moffitt Cancer Center, Tampa
Bond Bond Clinic, P.A., Winter Haven
North Mississippi and Oncology Associates, Tupelo
Ashland-Bellefonte Cancer Center, Ashland
Michiana Hematology Oncology, PC, South Bend
Northern Indiana Cancer Research Consortium, South Bend
Horizon Oncology Research, Inc., Lafayette
Joliet Oncology Hematology Associates, Joliet
OSF Saint Anthony Medical Center for Cancer Care, Rockford
MId-Illinois Hematology & Oncology Associates, Ltd., Normal
Westchase Clinical Associates, Houston
Compassionate Care Research Group, Inc., Riverside
Compassionate Care Research Group, Inc., Fountain Valley
Compassionate Care Research Group, Inc., Corona
Lead Sponsor
American Regent, Inc.
INDUSTRY